Selank: Calm Without the Crash — The Anxiety Peptide and the Real Evidence

If benzodiazepines are a sledgehammer for anxiety, Selank is pitched as something gentler: a small synthetic peptide that takes the edge off without the sedation, the foggy head, or the dependence. Developed by Russian researchers and used there as an anti-anxiety nasal spray, it has crossed into the Western biohacking world as a "calm without the crash" nootropic and a regular on lists of the best peptides for focus and cognition. The honest catch is that nearly all of its clinical evidence is Russian-language and small, and outside Russia it is an unapproved research chemical.

This page is the high-level map of the whole Selank compound. We cover what it actually is, how its proposed mechanism works across the GABA, serotonin, and BDNF systems, what it is studied for, the dosing ranges people report (it is usually used intranasally), the side-effect picture, and its split legal status. Each section is a clear overview; the deep-dive topics point to dedicated guides so this page stays a clean hub. Selank's better-known sibling, the focus peptide Semax, is a separate molecule and gets its own page.

Key Takeaways

• Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro), a stabilized analog of the natural immune peptide tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences (Wikipedia, "Selank", retrieved 2026-06-15).
• It is primarily an anti-anxiety (anxiolytic) peptide, described in a 2018 peer-reviewed review as having benzodiazepine-comparable anti-anxiety activity but without the sedation, dependence, or memory impairment (Protein and Peptide Letters, 2018).
• Its proposed mechanism is multi-system: allosteric modulation of the GABA system, effects on serotonin and other monoamines, and upregulation of BDNF, a brain-growth factor (Frontiers in Pharmacology, 2016).
• It is not FDA-approved and is an unapproved drug in the US, sold "for research use only." In Russia it is registered as a nasal-drop anxiolytic; that approval does not carry to Western regulators (Wikipedia, "Selank", retrieved 2026-06-15).
• The human evidence is limited and mostly Russian-language, including a reported comparison against the benzodiazepine medazepam in generalized anxiety disorder; it has not cleared a large Western randomized trial (Protein and Peptide Letters, 2018).
• Selank is usually used intranasally (as a nasal spray or drops), with reported doses commonly in the hundreds of micrograms per day. These are community/research figures, not validated dosing.

What is Selank?

Selank is a synthetic heptapeptide, a chain of seven amino acids, engineered as a longer-lasting version of tuftsin, a small immune-signaling peptide the body makes naturally. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, and it is studied mostly as an anti-anxiety and mild cognitive-support compound. It was created by Russian scientists and is best known there as an anti-anxiety nasal spray.

Chemically, Selank takes the active core of tuftsin (Thr-Lys-Pro-Arg) and adds a Pro-Gly-Pro tail to make it far more stable in the body, since natural tuftsin breaks down within seconds (Protein and Peptide Letters, "Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity", 2018, retrieved 2026-06-15). It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences (Wikipedia, "Selank", retrieved 2026-06-15). If injectable or intranasal peptides are new to you, start with our what are peptides and how peptides work guides.

The single most important fact about Selank in a Western context is its status: it is not approved by the FDA or any other Western regulator. In Russia it exists as a registered medicine; outside Russia, it lives in a small body of research and a large unapproved "research chemical" market. Read everything else here through that lens.

Citation capsule. Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, a stabilized analog of the endogenous immunomodulatory peptide tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is studied primarily as an anxiolytic. It is not approved by the FDA or any Western regulator. Source: Wikipedia, "Selank," 2026; Protein and Peptide Letters, 2018. PubChem CID 11765600; CAS 129954-34-3; ChemSpider 9940290; UNII TS9JR8EP1G.

How does Selank work?

Selank is thought to calm anxiety by nudging several brain systems at once rather than hitting one switch hard: it gently tunes the GABA system, shifts serotonin and other mood chemicals, and raises BDNF, a protein that supports brain cells. That multi-system, light-touch action is the proposed reason it can reduce anxiety without the heavy sedation of a benzodiazepine. Importantly, much of this picture comes from animal and gene-expression studies, not large human trials.

In plain terms, where a benzodiazepine forces the brain's main "brake" (the GABA system) hard and fast, Selank is described as a gentle modulator of that same system, working differently from benzodiazepines and without the same sedation or dependence (Protein and Peptide Letters, 2018, retrieved 2026-06-15). A 2016 gene-expression study found that Selank changed the activity of dozens of genes tied to GABA signaling in the rat brain, and that its pattern of effect correlated strongly with GABA's own (Frontiers in Pharmacology, "Selank Administration Affects the Expression of Genes Involved in GABAergic Neurotransmission", 2016, retrieved 2026-06-15).

Here is what each proposed mechanism contributes, in simple terms:

• GABA system (the calming brake): Selank is reported to act as a gentle allosteric modulator of GABA signaling, the brain's main calming pathway, working differently from benzodiazepines (Protein and Peptide Letters, 2018, retrieved 2026-06-15).
• Serotonin and monoamines (mood balance): it is reported to influence serotonin metabolism and the balance of mood-related brain chemicals (Wikipedia, "Selank", retrieved 2026-06-15).
• BDNF (brain-cell support): intranasal Selank raised BDNF in the hippocampus of rats, a growth factor linked to mood, learning, and resilience to stress (Wikipedia, "Selank", retrieved 2026-06-15).
• Enkephalin stability (the body's own calmers): Selank is reported to slow the breakdown of enkephalins, natural peptides involved in pain and mood regulation (Wikipedia, "Selank", retrieved 2026-06-15).

The receptor-and-signaling deep dive (exactly how allosteric modulation works, why BDNF matters for mood) is its own topic. We keep it at overview level here and link out to how peptides work for the foundations.

What is Selank used for?

Selank is studied and used mainly to reduce anxiety and stress, with secondary interest in mild cognitive support, mood, and immune modulation. None of these are FDA-approved uses; they are the directions Russian research and community use have pointed.

The headline use is anxiety. In Russia, Selank is positioned as a treatment for generalized anxiety and stress-related complaints, and the peer-reviewed literature frames it as an anxiolytic that works without the downsides of benzodiazepines (Protein and Peptide Letters, 2018, retrieved 2026-06-15). Its secondary reputation in the biohacking world is as a gentle "take the edge off and think more clearly" compound, distinct from a stimulant. Because Selank started life as a tuftsin analog, it also carries reported immune-modulating effects, an area still largely confined to animal and lab work.

A quick overview of the areas Selank is studied for, and where the evidence stands:

Because several of these are distinct future spokes, we keep them brief here. The honest headline: Selank's strongest identity is as an anxiolytic, and even there the human evidence base is small and region-specific.

How strong is the evidence for Selank?

The evidence for Selank is real but limited: a body of animal and mechanistic work plus several small human studies, most of them Russian-language and not held to Western trial standards. That is a very different situation from an FDA-reviewed medicine, and it is the most important thing to weigh.

The most cited human result is a reported comparison of intranasal Selank against the benzodiazepine medazepam in generalized anxiety disorder, in which Selank produced a similar reduction in anxiety symptoms (Protein and Peptide Letters, 2018, retrieved 2026-06-15). The same review describes Selank as having anxiolytic activity comparable to classical agents but without sedation, dependence, or the memory impairment associated with benzodiazepines. That is a genuinely interesting profile, but it rests on a research base that has not been replicated in large, independent Western randomized controlled trials.

Why the human evidence is harder to weigh

Two things make Selank's evidence harder to judge than a typical Western drug. First, much of the clinical work was published in Russian during and after its development at the Institute of Molecular Genetics, which limits how easily Western readers, regulators, and reviewers can scrutinize the methods and raw data (Wikipedia, "Selank", retrieved 2026-06-15). Second, a large share of the mechanistic findings, such as the BDNF increase and the GABA gene-expression changes, come from rats rather than people (Frontiers in Pharmacology, 2016, retrieved 2026-06-15). Animal and gene-expression results are valuable for understanding how a compound might work, but they do not establish that it works, or how safely, in humans at a given dose.

This matters for a practical reason. Selank has a longer real-world track record in Russia than many "research peptides," which is a point in its favor, but a national approval in one country is not the same as the multi-trial, independently reviewed evidence package behind an FDA-approved medicine. For a reader, the honest takeaway is that Selank sits in an unusual middle zone: more clinically used than most biohacking peptides, yet still investigational and unapproved everywhere outside its region of origin.

Our take: The most common mistake we see is flattening Selank into one of two cartoons, either "a proven Russian wonder-drug Western medicine is ignoring" or "just another unproven research chemical." Neither is right. It has a real, region-specific clinical history and a coherent mechanism, and it lacks the large independent trials that would let anyone outside Russia call it established.

What doses of Selank do people report using?

There is no validated Western dose for Selank, but it is almost always used intranasally, and reported research and community protocols cluster in the hundreds of micrograms per day, often run in short cycles. These are figures people report, not an established or recommended dose, and there is no FDA-reviewed label to anchor them.

The defining form nuance is the route: Selank is typically given as nasal drops or a nasal spray rather than by injection, partly because the Russian product is a nasal solution and partly because the nose offers a direct, needle-free path (Wikipedia, "Selank", retrieved 2026-06-15). Reported community and secondary-source dosing commonly lands around a few hundred micrograms per administration, sometimes split across the day, and Selank is frequently cycled (for example a few weeks on, then a break) rather than taken indefinitely. We label all of this as a community/research convention because no Western regulator has reviewed a dose, and rigorous public human pharmacokinetic data are thin (Protein and Peptide Letters, 2018, retrieved 2026-06-15).

The detailed titration schedule, drop-count math, reconstitution for lyophilized powder, and cycling specifics are a dedicated spoke. We cover only the high-level framing here and link out to the full Selank dosing and cycling guide, the how to vet peptide quality guide, and the general peptide injections guide for the less-common injectable form.

For orientation only, here is how people commonly describe the reported routes (not a recommendation):

Our take: Because Selank is needle-free and "gentle," it is easy to treat the nasal spray as casual. It is still an unapproved drug with thin Western pharmacokinetic data, and a precise-sounding microgram number repeated across vendor blogs is a community convention, not a validated dose. We never present it as one.

What are the side effects of Selank?

Because Selank has been studied mostly in small Russian trials and animal models, its full side-effect profile is not well characterized by Western standards; reported issues are generally mild, with no dependence or withdrawal described. "Generally mild but incompletely studied" is the honest headline, not "proven safe."

In the Russian clinical and peer-reviewed literature, Selank's defining selling point is what it lacks: unlike benzodiazepines, it is described as not causing sedation, dependence, or memory impairment (Protein and Peptide Letters, 2018, retrieved 2026-06-15). The most commonly reported real-world complaints relate to the intranasal route rather than the molecule itself. But because rigorous, independent long-term human safety data are limited, the responsible position is that the full profile, especially over long periods, is not established.

A hub-level overview of what is reported and what is uncertain:

• Commonly reported (mild): nasal or sinus irritation, throat irritation, and occasional nosebleeds, all tied to the nasal route; these are typically described as minor.
• Notably reported absences: no sedation, no dependence, and no withdrawal in the Russian literature, the main contrast with benzodiazepines (Protein and Peptide Letters, 2018, retrieved 2026-06-15).
• Quality-related risks: because the Western market is unregulated, contamination, mislabeled potency, or impurities are real concerns independent of the peptide itself. See how to vet peptide quality.
• Unknown: rigorous long-term human safety by Western standards, because the large independent studies do not exist.

This is the hub-level summary. A full side-effect deep-dive is a dedicated spoke: Selank side effects and safety deep-dive.

How does Selank compare to Semax?

Selank and Semax are the two best-known Russian "designer peptides," and they are easy to confuse, but they are different molecules built for different jobs: Selank is the calming, anti-anxiety peptide, while Semax is the focus-and-neuroprotection peptide. Both are unapproved outside Russia and both are usually used intranasally.

The cleanest way to hold them apart is origin and purpose. Selank is an analog of tuftsin, an immune-signaling peptide, and its leading reputation is anxiolytic: taking the edge off stress without sedation. Semax is an analog of a fragment of ACTH (specifically ACTH 4-10), and its leading reputation is cognitive and neuroprotective: sharpening focus and supporting the brain under stress. People sometimes describe the pair as "Selank to calm down, Semax to lock in," and some use them together, though that combination has not been validated in controlled trials.

That is the hub-level contrast, and it is deliberately brief. The full Semax story, including its cognitive mechanism, dosing, and the case for or against stacking the two, lives on its own page. We keep it short here to avoid overlapping that article: see the full Semax guide and the direct Semax vs Selank head-to-head.

Is Selank safe and legal?

Selank's legal status is split: it is a registered, used medicine in Russia, but it is not approved by the FDA or any Western regulator, where it is an unapproved drug sold only as a "research chemical." That status matters more than any single study.

On legality, the picture outside Russia is clear. Selank is not an FDA-approved drug, cannot be legally prescribed or sold as a medicine in the US, and is not a lawful dietary ingredient; the products sold online are unapproved research chemicals labeled "not for human consumption" (Wikipedia, "Selank", retrieved 2026-06-15). Its Russian registration as a nasal-drop anxiolytic does not transfer to the US, the EU, or other Western jurisdictions. On safety, the Russian clinical track record is more reassuring than for many research peptides, but "used in Russia and reassuring in small studies" is not the same as "established safe and effective" under the independent, multi-trial scrutiny Western approval requires.

For the full legal picture and how to evaluate a vendor before anything else, see are peptides legal and how to vet peptide quality. Athletes should also note that anti-doping rules treat non-approved substances strictly, so anyone subject to testing should check current prohibited-list status independently.

Our take: The single most common misunderstanding is treating Selank's Russian approval as if it settled the question for everyone. It does not. In the US it is an unapproved drug with no regulatory safety determination, sold "for research use only." A medicine approved in one country is not automatically vetted, legal, or safe to self-administer elsewhere.

How do people obtain Selank?

Outside Russia, the main way people access Selank is by buying unapproved "research chemical" nasal sprays, drops, or lyophilized powder online, which is a legal and safety gray market with no Western regulatory oversight. There is no legitimate "get a prescription" route for an unapproved drug in the US, outside of a clinical trial.

The research-peptide market is where most Western searches end up: vendors sell Selank "for research use only," and buyers use it off-label. That market carries real risks of mislabeled potency, impurities, and non-sterile product. If you are researching that path despite the risks, the responsible groundwork is the same as for any research peptide:

1. Confirm the legal status for your country and situation, including sport and workplace rules. See are peptides legal.
2. Demand a certificate of analysis (COA) from independent third-party testing, and learn to read it for identity and purity. See how to vet peptide quality.
3. Understand handling before anything else. Storage, reconstitution of powder, and sterile intranasal technique are not optional. See getting started with peptides.
4. Talk to a qualified clinician who can weigh your specific health situation, medications, and contraindications, especially if you already take anything for anxiety or mood.

We are describing what people do, not endorsing it. Using an unapproved drug means accepting unknown risks with no regulatory safety net.

A realistic look at expectations

Selank's "instant calm, zero downside" reputation is a simplification: the calming effect reported in studies is real but modest, and the cleanest evidence comes from small, region-specific trials, so expectations should stay grounded. Going in calibrated is part of using any of this information responsibly.

Two honest caveats sit on top of the hype. First, the strongest claim, anxiolytic effect comparable to a benzodiazepine without the sedation, comes from a research base that has not been independently replicated at scale in the West. Second, anxiety naturally rises and falls, and lifestyle factors (sleep, stimulants, stress load) move it a lot, which makes it easy to over-attribute a calmer week to a nasal spray. For grounded context on reading personal results, see peptides before and after.

Frequently Asked Questions

The bottom line

Selank is an unusual entry in the peptide world: a compound with a real, decades-long clinical history in Russia as an anti-anxiety nasal spray, a coherent multi-system mechanism, and a genuinely appealing pitch, calm without the sedation, dependence, or memory fog of a benzodiazepine. That track record sets it apart from the many peptides whose only evidence is a handful of rodent studies.

The other half of the story is discipline. Most of Selank's human evidence is small and Russian-language, it has never cleared a large independent Western trial, and outside Russia it is an unapproved drug sold only as a research chemical with no guarantee of what is in the bottle. The honest label is investigational. If you take one thing from this hub, let it be the gap between "used and reassuring in Russia" and "proven and approved for you," and the value of a qualified clinician in navigating it. From here, the natural next reads are the focus-peptide sibling Semax, plus how to vet peptide quality and are peptides legal.

Sources

• Wikipedia. "Selank." Retrieved 2026-06-15. https://en.wikipedia.org/wiki/Selank
• Vyunova, T.V., Andreeva, L., Shevchenko, K., Myasoedov, N. "Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity." Protein and Peptide Letters, 2018. Retrieved 2026-06-15. https://pubmed.ncbi.nlm.nih.gov/30255741/
• Volkova, A., et al. "Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission." Frontiers in Pharmacology, 2016. Retrieved 2026-06-15. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2016.00031/full
• Kasian, A., et al. "Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats." Behavioural Neurology / PMC, 2017. Retrieved 2026-06-15. https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/
• PubChem. "Selank (Compound CID 11765600)." National Library of Medicine. Retrieved 2026-06-15. https://pubchem.ncbi.nlm.nih.gov/compound/11765600
• Wikidata. "Selank (Q5810370)." Retrieved 2026-06-15. https://www.wikidata.org/wiki/Q5810370
• Examine. "Selank." Retrieved 2026-06-15. https://examine.com/supplements/selank/